(Q31122605)

29 June 2017

New insights into ADPKD molecular pathways using combination of SAGE and microarray technologies (English)

1 reference

29 June 2017

Hervé Husson

1

1 reference

29 June 2017

Partha Manavalan

2

1 reference

29 June 2017

Viatcheslav R Akmaev

3

1 reference

29 June 2017

Ryan J Russo

4

1 reference

29 June 2017

Brian Cook

5

1 reference

29 June 2017

Brenda Richards

6

1 reference

29 June 2017

Dana Barberio

7

1 reference

29 June 2017

Dongyu Liu

8

1 reference

29 June 2017

Xiaohong Cao

9

1 reference

29 June 2017

Gregory M Landes

10

1 reference

29 June 2017

Clarence J Wang

11

1 reference

29 June 2017

Bruce L Roberts

12

1 reference

29 June 2017

Katherine W Klinger

13

1 reference

29 June 2017

Shelley A Grubman

14

1 reference

29 June 2017

Douglas M Jefferson

15

1 reference

29 June 2017

Oxana Ibraghimov-Beskrovnaya

16

1 reference

29 June 2017

1 September 2004

1 reference

29 June 2017

1 reference

29 June 2017

84

1 reference

29 June 2017

3

1 reference

29 June 2017

497-510

1 reference

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

29 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

ERp44, a novel endoplasmic reticulum folding assistant of the thioredoxin family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Renal cystic disease. Insights from recent experimental investigations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Angiogenesis in autosomal-dominant polycystic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Autocrine induction of collagenase by serum amyloid A-like and beta 2-microglobulin-like proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. The American PKD1 Consortium (APKD1 Consortium)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Polycystic kidney disease: primary extracellular matrix abnormality or defective cellular differentiation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Cyst-derived cells do not exhibit accelerated growth or features of transformed cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Compromised cytoarchitecture and polarized trafficking in autosomal dominant polycystic kidney disease cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Autosomal-dominant polycystic kidney disease in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Autosomal dominant polycystic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Effect of serum amyloid A on selected in vitro functions of isolated human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Multiorgan mRNA misexpression in murine autosomal recessive polycystic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: recent advances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

CT in the evaluation of complicated autosomal dominant polycystic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Neutrophils and renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Flow cytometric immunodissection of the human nephron in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Inhibition of catalase and epoxide hydrolase by the renal cystogen 2-amino-4,5-diphenylthiazole and its metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Strong homophilic interactions of the Ig-like domains of polycystin-1, the protein product of an autosomal dominant polycystic kidney disease gene, PKD1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Beta4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: role in increased cell adhesion and migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Dynamics of gene expression revealed by comparison of serial analysis of gene expression transcript profiles from yeast grown on two different carbon sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Experimental design for gene expression microarrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Analysis of variance for gene expression microarray data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Interaction between RGS7 and polycystin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

The polycystic kidney disease 1 gene product modulates Wnt signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Expression of differentiation antigens and growth-related genes in normal kidney, autosomal dominant polycystic kidney disease, and renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Autosomal dominant polycystic kidney disease--in vitro culture of cyst-lining epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Association of cyclosporin A with acquired cystic kidney disease of the native kidneys in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Endoplasmic reticulum chaperones GRP78 and calreticulin prevent oxidative stress, Ca2+ disturbances, and cell death in renal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Polycystic kidney disease: Etiology, pathogenesis, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Inflammatory cytokine profile in autosomal dominant polycystic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Matrix metalloproteinases in tumor invasion: role for cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Molecular characteristics of non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Enhanced resistancy of thioredoxin-transgenic mice against influenza virus-induced pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Renal infections in autosomal dominant polycystic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Functional analysis of PKD1 transgenic lines reveals a direct role for polycystin-1 in mediating cell-cell adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Renal cysts in polycystic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

New insights into polycystic kidney disease and its treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Renal concentration of alpha-tocopherol: dependence on gender and lack of effect on polycystic kidney disease in Han:SPRD rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Issues in cDNA microarray analysis: quality filtering, channel normalization, models of variations and assessment of gene effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Serial analysis of gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Design issues for cDNA microarray experiments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Gene expression profiles in normal and cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

10.1016/J.YGENO.2004.03.009

7 January 2021

Identifiers

DOI

1 reference

29 June 2017

1 reference